Patents by Inventor Giuseppe Giaccone

Giuseppe Giaccone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR CONTINUOUS CELL CULTURE OF CANCER CELLS AND CANCER STEM CELLS
    Publication number: 20190161737
    Abstract: The present invention is directed towards compositions and methods of culturing cancer cells, with the methods comprising culturing cancer cells in the presence a cell culture medium while inhibiting the activity of Rho kinase (ROCK) in the cells during culturing.
    Type: Application
    Filed: July 26, 2017
    Publication date: May 30, 2019
    Applicant: Georgetown University
    Inventors: Maria Laura Aventaggiati, Giuseppe Giaccone
  • Use of GTF21 mutations in the prognosis of thymic cancers
    Patent number: 9493842
    Abstract: Disclosed are methods of determining the prognosis of thymic cancer in a subject comprising detecting a mutation in the general transcription factor IIi (GTF2I) genetic sequence or protein. The presence of a GTF2I mutation indicates that the thymic cancer is indolent.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: November 15, 2016
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Giuseppe Giaccone, Yisong Wang, Iacopo Petrini
  • USE OF GTF21 MUTATIONS IN THE PROGNOSIS OF THYMIC CANCERS
    Publication number: 20150284807
    Abstract: Disclosed are methods of determining the prognosis of thymic cancer in a subject comprising detecting a mutation in the general transcription factor IIi (GTF2I) genetic sequence or protein. The presence of a GTF2I mutation indicates that the thymic cancer is indolent.
    Type: Application
    Filed: April 2, 2015
    Publication date: October 8, 2015
    Inventors: Giuseppe Giaccone, Yisong Wang, Iacopo Petrini